ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.

Xiaohua Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.